Univest
Univest
  • Markets
  • Asian Hotels (East) vs Nifty 50: Share Price Performance Compared

    • September 8, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Asian Hotels (East) vs Nifty 50: Share Price Performance Compared

    A data-led look at how Asian Hotels (East) share price has performed against the Nifty 50 across multiple time frames.

    read more
  • Meson Valves India Ltd. Hits Upper Circuit on BSE, 25 September 2026

    • September 8, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Meson Valves India Ltd. Hits Upper Circuit on BSE, 25 September 2026

    Meson Valves India Ltd. hit upper circuit on BSE on 25 September 2026 at Rs 172.8, a 4.98% move. Price action, valuation and peer context.

    read more
  • Is Amanta Healthcare a Good Buy After Its Q1 FY27 Results?

    • September 8, 2026
    • Posted by: Lakshit Sharma
    • Category: Market
    No Comments
    Is Amanta Healthcare a Good Buy After Its Q1 FY27 Results?

    Amanta Healthcare Q1 FY27: revenue Rs 69 crore, PAT Rs 3.30 crore. Full results breakdown and whether the stock is a buy at current levels.

    read more
  • Astron Paper & Board Mill vs Nifty 50: Returns Compared

    • September 8, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Astron Paper & Board Mill vs Nifty 50: Returns Compared

    A data-led look at how Astron Paper & Board Mill share price has performed against the Nifty 50 across multiple time frames.

    read more
  • AKI India Share: Bull Case vs Bear Case for 2026

    • September 8, 2026
    • Posted by: Lakshit Sharma
    • Category: Market
    No Comments
    AKI India Share: Bull Case vs Bear Case for 2026

    AKI India bull case and bear case for 2026, based on CMP Rs 7.20, 52 week range Rs 3.80 to Rs 10.48, valuation and technical data.

    read more
  • Is Anuh Pharma a Good Buy After Its Q1 FY27 Results?

    • September 8, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Is Anuh Pharma a Good Buy After Its Q1 FY27 Results?

    Anuh Pharma Q1 FY27: revenue Rs 194 crore, PAT Rs 11 crore. Full results breakdown and whether the stock is a buy at current levels.

    read more
  • Akash Infra-Projects Share: Bull Case vs Bear Case for 2026

    • September 8, 2026
    • Posted by: Lakshit Sharma
    • Category: Market
    No Comments
    Akash Infra-Projects Share: Bull Case vs Bear Case for 2026

    Akash Infra-Projects bull case and bear case for 2026, based on CMP Rs 25.50, 52 week range Rs 22.80 to Rs 36.00, valuation and technical data.

    read more
  • Alkali Metals Share: Bull Case vs Bear Case for 2026

    • September 8, 2026
    • Posted by: Lakshit Sharma
    • Category: Market
    No Comments
    Alkali Metals Share: Bull Case vs Bear Case for 2026

    Alkali Metals bull case and bear case for 2026, based on CMP Rs 89.40, 52 week range Rs 46.80 to Rs 107.38, valuation and technical data.

    read more
  • Akme Fintrade India Share: Bull Case vs Bear Case for 2026

    • September 8, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Akme Fintrade India Share: Bull Case vs Bear Case for 2026

    Akme Fintrade India bull case and bear case for 2026, based on CMP Rs 9.14, 52 week range Rs 3.92 to Rs 11.10, valuation and technical data.

    read more
  • Albert David Share: Bull Case vs Bear Case for 2026

    • September 8, 2026
    • Posted by: Lakshit Sharma
    • Category: Market
    No Comments
    Albert David Share: Bull Case vs Bear Case for 2026

    Albert David bull case and bear case for 2026, based on CMP Rs 859.95, 52 week range Rs 579.90 to Rs 931.85, valuation and technical data.

    read more
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 2,713